Louisiana State University
Cytovale Aiming to Enter Sepsis Testing Market With Rapid, Direct-From-Blood, Point-of-Care Platform
Premium
The company's core technology analyzes the mechanical properties of single cells and uses those properties to understand cell state and behavior.
Cytovale Receives Additional $3.8M to Test Sepsis Diagnostic in SARS-CoV-2 Patients
In October the company received $15 million in funding from BARDA and venture capital firms to advance its early sepsis detection technology.
Researchers Developing Biomarker Test for Potentially Fatal GI Tract Infection in Preterm Babies
Premium
The research team said that its diagnostic biomarkers may help clinicians differentiate a fatal disease for preterm infants from other confounding conditions.
LSU Health Sciences Center New Orleans to Use OmniSeq Tumor Profiling Tech
LSU Health New Orleans and OmniSeq will collaborate to offer next-generation sequencing-based tumor profiling services to the institution's oncologists.